Enovis ENOV
NYSE ENOV
$26.17 -0.33 (-1.25%)
As of: Aug 20, 2026 · 3:59 PM EDT

Enovis (ENOV) Divestments (2025)

Enovis (ENOV) posted quarterly Divestments of $43.3 million for Q4 2025, up 2604.56% quarter-over-quarter from $1.6 million in Q2 2025.

Enovis (ENOV) Divestments (2025) Analysis & Trends

Enovis (ENOV) has reported Divestments for 1 consecutive years, with $43.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Divestments changed N/A year-over-year to $43.3 million; the TTM figure through Dec 2025 stood at $44.9 million (changed N/A YoY), while the FY2025 annual figure was $43.3 million, changed N/A from the prior year.
  • Divestments climbed to $43.3 million in Q4 2025 per ENOV's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Divestments topped out at $43.3 million in Q4 2025 and bottomed at $1.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 153.43 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Enovis 1.50 Bn 1.48 Bn 359.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 43.30 Mn
Apr 4, 2025 1.60 Mn